The first stop for professional medicines advice

Intrathecal medicines

29 results

RelevanceNewest firstOldest firstTitle
Applied filters

Rituximab: informing intrathecal risk assessment

11 August 2022Rituximab products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Diamorphine hydrochloride: informing intrathecal risk assessment

11 August 2022Diamorphine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Hydromorphone: informing intrathecal risk assessment

11 August 2022Hydromorphone products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Gentamicin: informing intrathecal risk assessment

11 August 2022Gentamicin products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Omnipaque: informing intrathecal risk assessment

11 August 2022Omnipaque products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Colistimethate sodium: informing intrathecal risk assessment

11 August 2022Colistimethate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Topotecan: informing intrathecal risk assessment

11 August 2022Topotecan products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Fluorescein: informing intrathecal risk assessment

11 August 2022Fluorescein products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Hydrocortisone acetate: informing intrathecal risk assessment

11 August 2022Hydrocortisone acetate products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration

Cytarabine: informing intrathecal risk assessment

11 August 2022Cytarabine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration